Global Pemphigus Vulgaris Market Valued at US$ 417.88 Mn. in 2021, Predicted to Reach Nearly US$ 678 Mn. by 2027
Market Size and Overview:
The global Pemphigus Vulgaris Market, a severe skin condition causing blisters on the skin and mucous membranes, was valued at US$ 417.88 million in 2021. According to the latest research report, it is expected to grow at a CAGR of 8.4% during the forecast period from 2022 to 2027, reaching a total revenue of nearly US$ 678 million. Pemphigus vulgaris, the most common type, leads to painful sores and blisters on the skin and in the mouth. While the exact cause remains unknown, experts believe it occurs when a person with a genetic predisposition encounters an environmental trigger. Treatments for Pemphigus Vulgaris include Corticosteroids, Immunosuppressants, Biological Therapies, and Intravenous Immunoglobulin (IVIG) Therapy.
Request for free sample@https://www.maximizemarketresearch.com/request-sample/65970
Research Methodology:
The comprehensive analysis of the Global Pemphigus Vulgaris Market presented in this report follows a rigorous research methodology, combining primary and secondary data sources. In-depth data analysis and extensive research have been carried out to provide stakeholders in the industry with valuable insights into market trends, growth drivers, restraints, and regional dynamics. The report employs PORTER and PESTEL analysis to assess the potential impact of micro-economic factors on the market.
Market Dynamics:
The market is witnessing an increasing preference for biological medicines over non-biological drugs due to fewer negative effects. However, the high cost and limited availability of biological drugs might restrain market growth. Researchers are actively focusing on Pemphigus Vulgaris Treatment and its market, given the limited options for treatment and the adverse effects of non-biological medications. Notably, Rituximab, a biological treatment, has shown promise as a first-line therapy for Pemphigus Vulgaris, receiving FDA “Breakthrough Designation” classification.
Market Segment Analysis:
Based on treatment, Corticosteroids are projected to hold the largest market share by 2027, providing relief by reducing inflammation and immune system activity. Hospital & Clinics are expected to be the fastest-growing segment due to the increasing prevalence of Pemphigus Vulgaris and higher treatment costs at hospitals.
Regional Insights: North America is expected to dominate the Pemphigus Vulgaris Market during the forecast period, owing to ongoing research and development for novel treatments and advancements in the healthcare sector. Europe and Asia Pacific are also anticipated to experience significant growth, driven by rising disease prevalence and technological advancements in the healthcare industry.
1 Global Pemphigus Vulgaris Market, by Treatment (2022-2027)
Corticosteroids
Immunosuppressants
Biological Therapies
Intravenous Immunoglobulin (IVIG) Therapy
Others
2 Global Pemphigus Vulgaris Market, by Route of Administration (2022-2027)
Intravenous
Subcutaneous
Oral
3 Global Pemphigus Vulgaris Market, by End-Users (2022-2027)
Hospitals & Clinics
Specialty Dermatology Clinics
Research & Academic Laboratories
Retailers
Pharmacy
E-Commerce
Market Key Players:
- Teva Pharmaceutical Industries
• Novartis Pharmaceuticals
• Hoffmann-La Roche
• Principia Biopharma, Inc.
• Argenx SE
• Pfizer Inc.
• Teligent Inc.
• GlaxoSmithKline LLC
• Almirall
• Biogen Inc.
• Syntimmune
• Sanofi
• Janssen Global Services
• Genentech Inc.
• Celltrion Inc.
• Amgen Inc.
• Samsung Bioepis.
• Fresenius Kabi USA.
• Hikma Pharmaceutical PLC
Request for free sample@https://www.maximizemarketresearch.com/request-sample/65970
Market Scope:
The report covers the period from 2017 to 2021, with a forecast for 2022 to 2027, presenting historical data and projected market size and trends. It segments the market based on Treatment (Corticosteroids, Immunosuppressants, Biological Therapies, Intravenous Immunoglobulin (IVIG) Therapy, and Others), Route of Administration (Intravenous, Subcutaneous, and Oral), and End-Users (Hospitals & Clinics, Specialty Dermatology Clinics, Research & Academic Laboratories, Retailers, Pharmacy, and E-Commerce). The geographical regions covered include North America, Europe, Asia Pacific, South America, and the Middle East and Africa.
Key questions answered in the Pemphigus Vulgaris Market are:
- What is Pemphigus Vulgaris?
- What are the factors driving the Pemphigus Vulgaris Market growth?
- What are the factors are limiting the Pemphigus Vulgaris Market growth?
- What was the Pemphigus Vulgaris market size in 2021?
- Which trends are expected to generate additional revenue for the Pemphigus Vulgaris market growth?
- What are the recent industry trends that can be implemented to generate additional revenue streams for the Pemphigus Vulgaris Market?
- What growth strategies are the players considering to increase their foothold in the Pemphigus Vulgaris Market?
- Who held the largest market share in the Pemphigus Vulgaris Market?
Key Offerings:
- Past Market Size and Competitive Landscape (2018 to 2021)
- Past Pricing and price curve by region (2018 to 2021)
- Market Size, Share, Size & Forecast by different segment | 2022−2029
- Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by region
- Market Segmentation – A detailed analysis by segment with their sub-segments and Region
- Competitive Landscape – Profiles of selected key players by region from a strategic perspective
- Competitive landscape – Market Leaders, Market Followers, Regional player
- Competitive benchmarking of key players by region
- PESTLE Analysis
- PORTER’s analysis
- Value chain and supply chain analysis
- Legal Aspects of business by region
- Lucrative business opportunities with SWOT analysis
- Recommendations
About Us
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 444 West Lake Street, Floor 17,
Chicago, IL, 60606, USA.
✆ +1 800 507 4489
✆ +91 9607365656
🖂 [email protected]
🌐 www.maximizemarketresearch.com
